Evaluation of Pharmacokinetic Interactions Between Vildagliptin and Digoxin in Healthy Volunteers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of Pharmacokinetic Interactions Between Vildagliptin and Digoxin in Healthy Volunteers

Published:2007-08 Issue:8 Volume:47 Page:998-1004
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

He Yan-Ling,Sabo Ron,Sunkara Gangadhar,Bizot Marie-Noëlle,Riviere Gilles-Jacques,Leon Selene,Ligueros-Saylan Monica,Dole William P.,Howard Dan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference33 articles.

1. Glucagon-like peptide-1 7-36: a physiological incretin in man;Kreymann;Lancet,1987

2. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses;Nauck;J Clin Endocrinol Metab,1986

3. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients;Vilsboll;Diabetes,2001

4. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects;Elahi;Regul Pept,1994

5. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus;Nauck;J Clin Invest,1993

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatics analysis to disclose shared molecular mechanisms between type-2 diabetes and clear-cell renal-cell carcinoma, and therapeutic indications;Scientific Reports;2024-08-19

2. A systematic review on the clinical pharmacokinetics of vildagliptin in healthy and disease populations;Expert Opinion on Drug Metabolism & Toxicology;2023-11-26

3. DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature;Frontiers in Molecular Biosciences;2023-05-23

4. Systems Pharmacology and Network Analysis to Advance Pharmacogenomics and Precision Medicine Decisions in Type-2 Diabetes Therapy;Future Pharmacology;2023-03-17

5. Dipeptidyl Peptidase 4 Inhibitors;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3